Mario Ernest's Insider Trades & SAST Disclosures
Mario Ernest's most recent trade in Soleno Therapeutics Inc was a trade of 6,500 Common Stock done . Disclosure was reported to the exchange on June 6, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Mario Ernest.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Soleno Therapeutics Inc | Ernest Mario | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 6,500 | 193,066 (0%) | 0% | 0 | Common Stock | |
| Soleno Therapeutics Inc | Ernest Mario | Director | 21 May 2024 | 62,000 | 186,566 (0%) | 0% | 4.5 | 279,000 | Common Stock | |
| Soleno Therapeutics Inc | Ernest Mario | Director | 21 May 2024 | 62,000 | 0 | - | - | Warrant (right to buy) | ||
| Soleno Therapeutics Inc | Mario Ernest | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Jan 2024 | 3,523 | 124,566 (0%) | 0% | 0 | Common Stock | |
| Soleno Therapeutics Inc | Ernest Mario | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Nov 2023 | 8,700 | 128,089 (0%) | 0% | 0 | Common Stock | |
| Soleno Therapeutics Inc | Ernest Mario | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 10,000 | 10,000 | - | - | Stock option (right to buy) | |
| Soleno Therapeutics Inc | Ernest Mario | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 2,666 | 2,666 | - | - | Stock option (right to buy) | |
| Soleno Therapeutics Inc | Ernest Mario | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 2,666 | 2,666 | - | - | Stock option (right to buy) | |
| Soleno Therapeutics Inc | Ernest Mario | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Mar 2022 | 930,000 | 930,000 | - | - | Warrant (right to buy) | |
| Soleno Therapeutics Inc | Ernest Mario | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Mar 2022 | 930,000 | 930,000 (2%) | 2% | - | Common Stock | |
| Soleno Therapeutics Inc | Ernest Mario | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Mar 2022 | 930,000 | 2,363,135 (5%) | 2% | - | Common Stock | |
| Soleno Therapeutics Inc | Ernest Mario | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Mar 2022 | 930,000 | 930,000 | - | - | Warrant (right to buy) | |
| Soleno Therapeutics Inc | Ernest Mario | Director | Grant, award, or other acquisition of securities at price $ 0.36 per share. | 31 Jan 2022 | 56,338 | 1,433,135 (3%) | 0% | 0.4 | 20,000 | Common Stock |
| Eyenovia Inc | Ernest Mario | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2021 | 9,653 | 9,653 | - | - | Stock Option (right to buy) | |
| Eyenovia Inc | Ernest Mario | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2021 | 6,963 | 382,706 (2%) | 0% | 0 | Common Stock, par value $.0001 | |
| Soleno Therapeutics Inc | Ernest Mario | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2021 | 26,888 | 1,376,797 (3%) | 0% | 0 | Common Stock | |
| Soleno Therapeutics Inc | Ernest Mario | Director | Grant, award, or other acquisition of securities at price $ 0.91 per share. | 30 Jul 2021 | 21,978 | 1,349,909 (3%) | 0% | 0.9 | 20,000 | Common Stock |
| Soleno Therapeutics Inc | Ernest Mario | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 31,862 | 31,862 | - | - | Employee stock option (right to buy) | |
| Soleno Therapeutics Inc | Ernest Mario | Director | Grant, award, or other acquisition of securities at price $ 1.21 per share. | 30 Apr 2021 | 16,529 | 1,176,416 (2%) | 0% | 1.2 | 20,000 | Common Stock |
| Soleno Therapeutics Inc | Ernest Mario | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 8,928 | 1,157,804 (2%) | 0% | 0 | Common Stock | |
| Eyenovia Inc | Ernest Mario | Director | 15 Jan 2021 | 41,216 | 375,743 (2%) | 0% | 2.3 | 93,560 | Common Stock, par value $.0001 | |
| Eyenovia Inc | Ernest Mario | Director | 15 Jan 2021 | 41,216 | 0 | - | - | Class A Warrant | ||
| Soleno Therapeutics Inc | Ernest Mario | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2021 | 40,000 | 40,000 | - | - | Employee stock option (right to buy) | |
| Soleno Therapeutics Inc | Ernest Mario | Director | Grant, award, or other acquisition of securities at price $ 1.74 per share. | 30 Oct 2020 | 10,057 | 1,148,876 (2%) | 0% | 1.7 | 17,499 | Common Stock |
| Eyenovia Inc | Ernest Mario | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2020 | 9,820 | 9,820 | - | - | Stock Option (right to buy) | |
| Eyenovia Inc | Ernest Mario | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2020 | 7,288 | 334,527 (1%) | 0% | 0 | Common Stock, par value $.0001 | |
| Soleno Therapeutics Inc | Ernest Mario | Director | Grant, award, or other acquisition of securities at price $ 1.72 per share. | 31 Jul 2020 | 10,174 | 10,174 (0%) | 0% | 1.7 | 17,499 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges